Michael MergesDirector of Analytical Science & Technology at Emergent BioSolutions
Mike Merges is Director of Analytical Sciences and Technology at Emergent Biosolutions where he oversees the technical transfer and validation of analytical methods supporting biologics manufacturing and analytical technology innovation development. Mike has over 30 years of experience in analytical method development and validation with a background in cell biology, immunology and virology. He joined Emergent from Catalent where he was Director of Strategic Growth for Catalent Biologics managing the accelerated growth of Catalent’s Biologics Analytical Services spanning business development, technology innovations and technical advisory to Catalent’s Biologics network. Prior to working at Catalent, Mike was Associate Director of Bioservices at Lonza. Mike performed vaccine research at the University of Maryland's Institute of Human Virology, the National Cancer Institute and Johns Hopkins University. Mike received his MS in immunology from Hood College and his BS in microbiology from The Pennsylvania State University.